EUVIMEDEUVIMED entdecken
Open Access

A CRISPR-based genome-wide loss-of-function screen defines a role of host metabolism in regulating hepatitis B virus infection

Tadashi Inuzuka, Karim Mouzannar, Min Zhang, Regina Umarova, Seung Bum Park, Takuro Uchida, Christopher D Ma, T Jake Liang

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.11.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Tadashi Inuzuka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20814, U…. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis B, CRISPR-Cas Systems, Host-Pathogen Interactions. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) co-opts and interacts with an extensive array of host factors for productive infection. Herein, we develop an HBV reporter virus expressing red fluorescent protein (HBV-RFP) that is suitable for a CRISPR-based genome-wide screen for HBV host dependency factors. HepG2NTCP/Cas9 cells were transduced with a pooled lentiviral library of single-guide RNA (sgRNA) targeting 19,114 human genes, edited and infected with HBV-RFP. RFP-low cells were sorted using fluorescence-activated cell sorting. The sorted cells were expanded and underwent two additional rounds of infection and sorting to enrich for sgRNA-targeted proviral host factors. By next-generation sequencing and bioinformatic analyses, we identified 63 genes as candidate host proviral factors, including known HBV proviral factors: RXRA, POLL, LDLR, and NTCP. Among the novel candidate genes, knockout of 12 genes significantly decreased HBV replication markers. Validation using siRNA knockdown in primary human hepatocytes confirmed several factors including the monoacylglycerol acyltransferase 2 (MOGAT2) gene as a bona fide HBV proviral factor. Further analysis with MGAT2 inhibitors demonstrated that inhibition of MOGAT2 activity impairs HBV transcription and replication. Our study demonstrates the value of the HBV reporter system in identifying previously unrecognized host metabolic factors important for HBV infection, offering a potential avenue for therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusHepatitis BCRISPR-Cas SystemsHost-Pathogen InteractionsHumansHep G2 CellsVirus ReplicationHepatocytesRNA, Guide, CRISPR-Cas SystemsGene EditingClustered Regularly Interspaced Short Palindromic Repeats

Stichwörter der Autor:innen

CYP7A1HBV reporterMGAT2MOGAT2genome-wide screen

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20814, USA; Department of Gastroenterology and Hepatology, Kyoto University, G…
  • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20814, USA.
  • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20814, USA; Department of Gastroenterology and Hepatology, Oita University, Gr…
  • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20814, USA. Electronic address: jakel@bdg10.niddk.nih.gov.

Förderung

  • Intramural NIH HHS
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Inuzuka, T., Mouzannar, K., Zhang, M., Umarova, R., Park, S. B., Uchida, T., Ma, C. D., & Liang, T. J. (2025). A CRISPR-based genome-wide loss-of-function screen defines a role of host metabolism in regulating hepatitis B virus infection. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.11.032

Vancouver

Inuzuka T, Mouzannar K, Zhang M, Umarova R, Park SB, Uchida T, et al. A CRISPR-based genome-wide loss-of-function screen defines a role of host metabolism in regulating hepatitis B virus infection. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.11.032

BibTeX
@article{Inuzuka2025,
  author = {Inuzuka, Tadashi and Mouzannar, Karim and Zhang, Min and Umarova, Regina and Park, Seung Bum and Uchida, Takuro and Ma, Christopher D and Liang, T Jake},
  title = {A CRISPR-based genome-wide loss-of-function screen defines a role of host metabolism in regulating hepatitis B virus infection},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.11.032}
}
Kostenlos starten →